Ito S. Mother and child: medication use in pregnancy and lactation. Clin Pharmacol Ther. 2016;100(1):8–11.

Article  CAS  PubMed  Google Scholar 

Alwan S, Bandoli G, Chambers CD. Maternal use of selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. Clin Pharmacol Ther. 2016;100(1):34–41.

Article  CAS  PubMed  Google Scholar 

Food U, Administration D. Clinical lactation studies: considerations for study design. Guidance for industry. Draft guidance. Silver Spring: Food and Drug Administration; 2019.

Google Scholar 

Yeung CHT, Ito S, Autmizguine J, Edginton AN. Incorporating breastfeeding-related variability with physiologically based pharmacokinetic modeling to predict infant exposure to maternal medication through breast milk: a workflow applied to lamotrigine. AAPS J. 2021;23(4):70.

Article  CAS  PubMed  Google Scholar 

Nauwelaerts N, Macente J, Deferm N, Bonan RH, Huang MC, Van Neste M, et al. Generic workflow to predict medicine concentrations in human milk using physiologically-based pharmacokinetic (PBPK) modelling—a contribution from the ConcePTION project. Pharmaceutics. 2023;15(5):1469.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pansari A, Faisal M, Jamei M, Abduljalil K. Prediction of basic drug exposure in milk using a lactation model algorithm integrated within a physiologically based pharmacokinetic model. Biopharm Drug Dispos. 2022;43(5):201–12.

Article  CAS  PubMed  Google Scholar 

Weisskopf E, Guidi M, Fischer CJ, Bickle Graz M, Beaufils E, Nguyen KA, et al. A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: prediction of infant drug exposure through breast milk. Br J Clin Pharmacol. 2020;86(8):1642–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Monfort A, Cardoso E, Eap CB, Fischer Fumeaux CJ, Graz MB, Morisod Harari M, et al. Infant exposure to fluvoxamine through placenta and human milk: a case series—a contribution from the ConcePTION project. Front Psychiatry. 2023;14:1167870.

Article  PubMed  PubMed Central  Google Scholar 

Chalifour B, Holzhausen EA, Lim JJ, Yeo EN, Shen N, Jones DP, et al. The potential role of early life feeding patterns in shaping the infant fecal metabolome: implications for neurodevelopmental outcomes. NPJ Metab Health Dis. 2023;1(1):2.

Article  PubMed  PubMed Central  Google Scholar 

Yeung CHT, Fong S, Malik PRV, Edginton AN. Quantifying breast milk intake by term and preterm infants for input into paediatric physiologically based pharmacokinetic models. Matern Child Nutr. 2020;16(2): e12938.

Article  PubMed  PubMed Central  Google Scholar 

Delaney SR, Malik PRV, Stefan C, Edginton AN, Colantonio DA, Ito S. Predicting escitalopram exposure to breastfeeding infants: integrating analytical and in silico techniques. Clin Pharmacokinet. 2018;57(12):1603–11.

Article  CAS  PubMed  Google Scholar 

Kent JC, Mitoulas LR, Cregan MD, Ramsay DT, Doherty DA, Hartmann PE. Volume and frequency of breastfeedings and fat content of breast milk throughout the day. Pediatrics. 2006;117(3):e387–95.

Article  PubMed  Google Scholar 

Mian P, Allegaert K, Conings S, Annaert P, Tibboel D, Pfister M, et al. Integration of placental transfer in a fetal-maternal physiologically based pharmacokinetic model to characterize acetaminophen exposure and metabolic clearance in the fetus. Clin Pharmacokinet. 2020;59(7):911–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu XI, Momper JD, Rakhmanina NY, Green DJ, Burckart GJ, Cressey TR, et al. Physiologically based pharmacokinetic modeling framework to predict neonatal pharmacokinetics of transplacentally acquired emtricitabine, dolutegravir, and raltegravir. Clin Pharmacokinet. 2021;60(6):795–809.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pathirana J, Munoz FM, Abbing-Karahagopian V, Bhat N, Harris T, Kapoor A, et al. Neonatal death: case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2016;34(49):6027–37.

Article  PubMed  PubMed Central  Google Scholar 

Maharaj AR, Barrett JS, Edginton AN. A workflow example of PBPK modeling to support pediatric research and development: case study with lorazepam. AAPS J. 2013;15(2):455–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maharaj AR, Edginton AN. Physiologically based pharmacokinetic modeling and simulation in pediatric drug development. CPT Pharmacometr Syst Pharmacol. 2014;3(11): e150.

Article  CAS  Google Scholar 

Sinha J, Karatza E, Gonzalez D. Physiologically-based pharmacokinetic modeling of oxcarbazepine and levetiracetam during adjunctive antiepileptic therapy in children and adolescents. CPT Pharmacometr Syst Pharmacol. 2022;11(2):225–39.

Article  CAS  Google Scholar 

Maglalang PD, Sinha J, Zimmerman K, McCann S, Edginton A, Hornik CP, et al. Application of physiologically based pharmacokinetic modeling to characterize the effects of age and obesity on the disposition of levetiracetam in the pediatric population. Clin Pharmacokinet. 2024;63(6):885–99.

Article  CAS  PubMed  Google Scholar 

Coupez R, Nicolas JM, Browne TR. Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid. Epilepsia. 2003;44(2):171–8.

Article  CAS  PubMed  Google Scholar 

Review of environmental assessment for KEPPRA® oral solution (NDA 021‐505). October 31, 2002 ed; 2022.

Strolin Benedetti M, Whomsley R, Nicolas JM, Young C, Baltes E. Pharmacokinetics and metabolism of 14C-levetiracetam, a new antiepileptic agent, in healthy volunteers. Eur J Clin Pharmacol. 2003;59(8–9):621–30.

Article  CAS  PubMed  Google Scholar 

Salerno SN, Edginton A, Gerhart JG, Laughon MM, Ambalavanan N, Sokol GM, et al. Physiologically-based pharmacokinetic modeling characterizes the CYP3A-mediated drug-drug interaction between fluconazole and sildenafil in infants. Clin Pharmacol Ther. 2021;109(1):253–62.

Article  CAS  PubMed  Google Scholar 

Kacirova I, Grundmann M, Brozmanova H. Umbilical cord, maternal milk, and breastfed infant levetiracetam concentrations monitoring at delivery and during early postpartum period. Pharmaceutics. 2021;13(3):398.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patsalos PN. Clinical pharmacokinetics of levetiracetam. Clin Pharmacokinet. 2004;43(11):707–24.

Article  CAS  PubMed  Google Scholar 

Yeung CHT, Autmizguine J, Dalvi P, Denoncourt A, Ito S, Katz P, et al. Maternal ezetimibe concentrations measured in breast milk and its use in breastfeeding infant exposure predictions. Clin Pharmacokinet. 2024;63(3):317–32.

Article  CAS  PubMed  Google Scholar 

Yeung CHT, Bertrand KA, Best BM, Capparelli E, Chambers CD, Hajducek DM, et al. Cannabidiol exposure through maternal marijuana use: predictions in breastfed infants. Clin Pharmacokinet. 2023;62(11):1611–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dubinsky S, Malik P, Hajducek DM, Edginton A. Determining the effects of chronic kidney disease on organic anion transporter1/3 activity through physiologically based pharmacokinetic modeling. Clin Pharmacokinet. 2022;61(7):997–1012.

Article  CAS  PubMed  Google Scholar 

Johannessen SI, Helde G, Brodtkorb E. Levetiracetam concentrations in serum and in breast milk at birth and during lactation. Epilepsia. 2005;46(5):775–7.

Article  CAS  PubMed  Google Scholar 

Drugs and Lactation Database (LactMed®). 2006 2022 Nov 30 [cited 2023 July 24]. https://www.ncbi.nlm.nih.gov/books/NBK501229/.

Tomson T, Palm R, Kallen K, Ben-Menachem E, Soderfeldt B, Danielsson B, et al. Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation. Epilepsia. 2007;48(6):1111–6.

Article  CAS  PubMed